Connection

Majdi Al-Hasan to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Majdi Al-Hasan has written about Anti-Bacterial Agents.
Majdi Al-Hasan
Connection Strength
8.515
Anti-Bacterial Agents
  1. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
    View in: PubMed
    Score: 0.484
  2. Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target. Clin Infect Dis. 2021 06 15; 72(12):2121-2123.
    View in: PubMed
    Score: 0.473
  3. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients? Drugs Aging. 2020 09; 37(9):627-633.
    View in: PubMed
    Score: 0.448
  4. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
    View in: PubMed
    Score: 0.441
  5. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
    View in: PubMed
    Score: 0.415
  6. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289.
    View in: PubMed
    Score: 0.412
  7. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.405
  8. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
    View in: PubMed
    Score: 0.382
  9. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
    View in: PubMed
    Score: 0.371
  10. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.365
  11. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.356
  12. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.355
  13. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.342
  14. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.341
  15. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.339
  16. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.330
  17. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
    View in: PubMed
    Score: 0.299
  18. Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60.
    View in: PubMed
    Score: 0.232
  19. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009 Jul; 64(1):169-74.
    View in: PubMed
    Score: 0.205
  20. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009 Apr; 53(4):1386-94.
    View in: PubMed
    Score: 0.200
  21. Temporal Association between Influenza Vaccination Coverage and Ambulatory Antibiotic Use in Children. Pediatr Infect Dis J. 2022 07 01; 41(7):600-602.
    View in: PubMed
    Score: 0.127
  22. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
    View in: PubMed
    Score: 0.114
  23. Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 04; 42(4):503-505.
    View in: PubMed
    Score: 0.111
  24. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
    View in: PubMed
    Score: 0.107
  25. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
    View in: PubMed
    Score: 0.106
  26. COPD Exacerbations - A Target for Antibiotic Stewardship. N Engl J Med. 2019 07 11; 381(2):174-175.
    View in: PubMed
    Score: 0.104
  27. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
    View in: PubMed
    Score: 0.096
  28. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
    View in: PubMed
    Score: 0.094
  29. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.087
  30. Comparison of ?-lactam plus aminoglycoside versus ?-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017 Feb; 29(1):30-37.
    View in: PubMed
    Score: 0.084
  31. Bloodstream infections and central line-associated bloodstream infections. Surg Clin North Am. 2014 Dec; 94(6):1233-44.
    View in: PubMed
    Score: 0.074
  32. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscesses. Am J Med Sci. 2013 Oct; 346(4):341-4.
    View in: PubMed
    Score: 0.069
  33. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr; 60(4):278-85.
    View in: PubMed
    Score: 0.054
  34. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation. Pharmacotherapy. 2023 01; 43(1):85-95.
    View in: PubMed
    Score: 0.033
  35. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey. World J Emerg Surg. 2022 03 17; 17(1):17.
    View in: PubMed
    Score: 0.031
  36. Novel method of calculating adjusted antibiotic use by microbiological burden. Infect Control Hosp Epidemiol. 2021 06; 42(6):688-693.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.